Glycemic Management and Clinical Outcomes in Underserved Minority Kidney Transplant Recipients with Type 2 and Posttransplantation Diabetes: A Single-Center Retrospective Study

Little is known about glycemic management, particularly with novel cardio-nephroprotecive agents, in underserved minority kidney transplant recipients with pre-transplant type 2 (T2DM) and posttransplantation diabetes mellitus (PTDM). We assessed glycemic management and outcomes in this high-risk population.

Source: Diabetes Research and Clinical Practice - May 18, 2020 Category: Endocrinology Authors: Sandra Aleksic, Ruth Eisenberg, Effie Tsomos, Sara Zahedpour Anaraki, Emily Japp, Laxmi Upadhyay, Wenzhu Bi Mowrey, Enver Akalin, Joel Zonszein Source Type: research